insights_auto
Why is GANX down 5.75%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$0.98
arrow_downward
-5.75%(-0.060) 1D
Nov 16, 9:45:00 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.01
High
$1.08
Low
$0.95
Mkt. cap
43.64M
Avg. vol.
527.99K
Volume
74.44K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.01
High
$1.08
Low
$0.95
Mkt. cap
43.64M
Avg. vol.
527.99K
Volume
74.44K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Premarket Losers on Nov. 16, 2026: COIN, LITE, COHR
Kitco
·
2 hours ago
S&P 500, Nasdaq futures fall ahead of Nvidia earnings, Anthropic IPO
Crypto News
·
3 hours ago
Bitget launches rToken Earn for tokenized S&P 500, Nasdaq-100 ETFs
FXEmpire
·
1 hour ago
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com